Long chain lipid based tamoxifen NLC. Part I: Preformulation studies, formulation development and physicochemical characterization

This publication has 47 references indexed in Scilit:

• Duloxetine HCl Lipid Nanoparticles: Preparation, Characterization, and Dosage Form Design
  AAPS PharmSciTech, 2011
• The effect of the oral administration of polymeric nanoparticles on the efficacy and toxicity of tamoxifen
  Biomaterials, 2011
• Development, evaluation and clinical studies of Acitretin loaded nanostructured lipid carriers for topical treatment of psoriasis
  International Journal of Pharmaceutics, 2010
• Effects of epigallocatechin gallate on the oral bioavailability and pharmacokinetics of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats
  Anti-Cancer Drugs, 2009
• Cancer Statistics, 2008
  CA: A Cancer Journal for Clinicians, 2008
• Physicochemical characterization andin vitrorelease studies of ascorbyl palmitate-loaded semi-solid nanostructured lipid carriers (NLC gels)
  Journal of Microencapsulation, 2008
• Preparation, Characterization and In Vitro Evaluation of Solid Dispersions Containing Docetaxel
  Drug Development and Industrial Pharmacy, 2008
• The metastatic cascade in prostate cancer
  Surgical Oncology, 2006
• New insights in the lymphatic spread of oesophageal cancer and its implications for the extent of surgical resection
  Best Practice & Research Clinical Gastroenterology, 2006
• Potential for lymphatic targeting of peptides
  Journal of Controlled Release, 1997